Ajmaline

西萝芙木碱

Report date: 2022/02/18 16:38:16
NME

Base Information

Drug NameAjmaline
Drug Alias Name西萝英木碱Rauwolfine西罗芙本碱阿义马林阿义吗林 +[14
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsDeath, SuddenBrugada SyndromeArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsArrhythmias, Cardiac
Inactive IndicationsDeath, SuddenBrugada Syndrome

Other Information

ATC CodeC01BA05